Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 454 across all filing types
Latest filing 2020-08-13 Capital/Financing Update
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Appendix 2A - Exercise of Options and Cleansing Notice 11 pages 407.7KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities being quoted, and the circumstances of the issue. This form is a regulatory announcement related to capital markets activity, specifically the listing or quotation of new securities following options being exercised or convertible securities converted. It is not a financial report, earnings release, or management discussion. It is a formal regulatory filing announcing a capital market transaction. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a report publication announcement, but a substantive regulatory filing about capital changes.
2020-08-13 English
Appendix 2A - Release from Escrow 9 pages 204.5KB
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 2A Application for quotation of +securities' and references ASX Listing Rules and securities quotation. It is an application form for the quotation of securities on the Australian Securities Exchange (ASX). The content includes details about the entity, type of securities, and escrow periods, which are typical for a securities quotation application. This is not a financial report, earnings release, or management discussion. It is a regulatory announcement related to capital markets and securities listing. According to the filing definitions, this fits best under 'Capital/Financing Update (CAP)' as it relates to updates on company fundraising, financing activities, or capital structure changes, specifically the quotation of securities.
2020-08-02 English
Notice of Release from Escrow 2 pages 192.2KB
Share Issue/Capital Change Classification · 100% confidence The document is an ASX announcement dated 24 July 2020 regarding the release of securities from escrow pursuant to ASX Listing Rule 3.10A. It details the number of shares being released and the dates of release. The content is a regulatory announcement about capital structure changes specifically related to escrowed shares being released. The document is short (2415 characters) and does not contain financial statements or detailed financial data. It is not a report but an announcement about share capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2020-07-23 English
Change in substantial holding 3 pages 139.8KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and shareholdings of a substantial holder, Elixxir Ltd, including dates and quantities of share transactions. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of Major Shareholding Notification (MRQ). The document is not a financial report, management announcement, or other types of filings. Therefore, the correct classification is MRQ.
2020-07-23 English
Investor Update Webinar 14 pages 1.1MB
Investor Presentation Classification · 95% confidence The document is an ASX announcement dated 23 July 2020, titled 'Investor Update Webinar – July 2020' for Little Green Pharma Ltd. It announces an upcoming investor webinar presentation and references an investor presentation released on 22 July 2020, which is included in the document. The content includes a detailed corporate overview, business model, shareholder information, and forward-looking statements. The document is informational and promotional in nature, focusing on company strategy, market position, and investor engagement. It does not contain financial statements, audit information, or regulatory certifications. It is not a transcript of a call but rather an announcement and presentation material for investors. Therefore, it fits the definition of an Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2020-07-22 English
Quarterly Activities Report and Appendix 4C 10 pages 829.7KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement dated 22 July 2020 titled 'Quarterly Activities Report and Appendix 4C - June 2020'. It contains detailed operational highlights, financial data including revenue, cash flow, and expenditure for the quarter ending 30 June 2020. It includes a reconciliation of use of funds, a message from the Managing Director, and the Appendix 4C cash flow report which is a regulatory requirement for quarterly reporting by listed entities on the ASX. The document is approximately 15,000 characters long and contains substantive financial data and analysis for the quarter, not merely an announcement or a certification. The presence of the Appendix 4C cash flow report and detailed quarterly operational and financial information clearly identifies this as a comprehensive interim/quarterly report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q4 2020
2020-07-21 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.